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The type I keratin 19 is unusual in its tissue distribution in 
that under normal circumstances it does not seem to be re- 
stricted, as the other keratins are, to expression in either 
stratified or simple epithelia. In addition to the previously 
reported distribution of keratin 19 in human tissues, we have 
observed keratin 19 in epidermal basal cells, in a defined 
region of the hair follicle, and in nipple epidermis. We no- 
ticed that expression of keratin 19 appears to be especially 
characteristic of regions of labile or variable cellular differen- 
tiation as indicated by the presence of multiple keratin phe- 
notypes in close proximity to each other. Using a monoclonal 
antibody recognizing keratin 19 (LP2K) to screen a human 
placenta cDNA expression library, we have isolated, cloned, 
and sequenced cDNA coding for full-length human keratin 
19, as confirmed by its reactivity with several other known 
anti-keratin 19 monoclonal antibodies and by the near iden- 
tity of its sequence with that of the bovine keratin 19 homo- 
logue. This similarity extends to both proteins being trun- 
cated at the C-terminal end to only 13 amino acids beyond 
the rod domain. Although the amino acid homology over the 
N-terminal and helical rod domains is particularly high, the 
human and bovine proteins diverge substantially over the 
short C-terminal domain, which suggests that this region has 
no conserved function. Comparison with other type I kera- 
tins indicates that the closest evolutionary neighbors of kera- 
tin 19 are keratinocyte keratins, probably 13 and 14, and not 
the simple epithelial keratin 18. Assessing the histochemistry 
and sequence data together, we propose that the cell may use 
this apparently deficient keratin as a “neutral” keratin. While 
unimpaired in its ability to polymerize (keeping the cell inte- 
grated into the epithelial sheet via filament-desmosome net- 
works), keratin 19 ex ression does not irrevocably commit a 
cell to any one of t f: e local differentiation options. Such 
predicted differentiational flexibility may also imply vulner- 
ability to transformation.]lnoestDermatol92:707- 716,1989 
T 
, he keratin family of intermediate filaments consists of 
at least 19 individual epithelial keratin polype tides 
[I], or 27 including the “hard” hair keratins [2 P , and 
each appears!to be the product of a different keratin 
gene. Different combinations of these intermediate 
filament proteins are expressed in a tissue-specific manner, but it has 
still not been possible to demonstrate their primary function in an 
experimental context. The ubiquitous expression of keratins by epi- 
thelial cells together with the structural complexity of the transcel- 
lular filament-desmosome network in all epithelia suggest that ker- 
atin filaments are essential for the function of an epithelium. Yet 
our current understanding of keratin chemistry and biology is insuf- 
ficient to explain the need for such extensive heterogeneity. 
The smallest keratin, keratin 19, was first detected in squamous 
cell carcinoma lines [3], and it is identifiable by its characteristically 
low molecular weight on SDS gels at 40 kD. It is generally regarded 
as being characteristic of simple epithelia (see Ref 4) such as intes- 
tine, kidney collecting ducts, gallbladder, mesothelium, and glan- 
dular secretory cells (see Ref 5 for review). Keratin 19 has, in fact, an 
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unusually wide tissue distribution, and has now been reported to be 
present, in significant quantities and under apparently normal con- 
ditions, in both stratified and squamous epithelia [6- 121. The gene 
for the bovine protein homologous to keratin 19 was recently se- 
quenced [I 31, and its sequence suggested that this keratin was trun- 
cated, accounting for its low molecular weight. Our preliminary 
observations on the cDNA sequence of human keratin 19 from 
simple epithelium supported this finding [14], and recently a second 
report of a sequence for human keratin 19 has been published [ 151 
which is almost identical to ours, from cDNA isolated from strati- 
fied epithelial cells (keratinocytes). 
This paper describes the use of a monoclonal antibody specific for 
keratin 19, LP2K, to examine the cellular distribution of this keratin 
within various tissues, including a population of basal keratinocyte 
cells within normal hair follicles, structures previously reported as 
not containing keratin 19 [16,17, but see 7,121. This antibody was 
used to identify cDNA clones coding for human keratin 19 which 
were expressed within a Agtl 1 library of human placenta, and we 
describe our subsequent analysis of this protein in terms of its rela- 
tionship to other keratins. Combining the histochemistry data with 
the sequence analysis, it seems likely that keratin 19, a keratinocyte 
keratin which is only more distantly related to simple epithelial 
keratin 18, has been conserved through evolution, especially be- 
cause of its lack of a tail-domain. The lack of a functional C-termi- 
nal domain in keratin 19 may reflect deferred committment to one 
of multiple differentiation pathways open to the cells expressing 
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keratin I9 in these tissues without sacrificing the essential keratin 
filament function of forming a transcellular desmosome-filament 
complex for structural integrity of the epithelium. 
METHODS 
Monoclonal Antibodies The monoclonal antibody LP2K was 
derived from BALB/c mice as described previously [ 181 using soni- 
cated cytoskeleton fractions [material insoluble in 1% Nonidet-P40 
(N-P40)] from SVK14 cells (SV40-transformed human neonatal 
keratinocytes: 19) as the immunogen. Positive hybrids were se- 
lected using a microimmunofluorescence assay [20] on SVK14 cells 
and selected cells were cloned in soft agarose [18]. Other monoclo- 
nal antibodies used that were reported to react with keratin 19 were 
BA16 and BA17 [6], A53-B/A2 [21], KM4.62 [22] (BioMakor, 
Rehovot, Israel) and (not monospecific) KA4 [23], AEl [24], and 
anti-IFA [25]. Antibodies LE61 (to keratin 18) and LE41 (to keratin 
8) [18] were also used as controls. 
Immunoblotting Cytoskeleton extracts were made by washing 
cultured cells in phosphate buffered saline (PBS), lysing in 0.1% 
N-P40 (in 10 mM Tris-HCl pH 7.4,150 mM NaCl, 3 mM EDTA) 
for 5 - 10 min and further extracting the pellet in a high salt solution 
(1.5M KCl, 10 mM Tris-HCl pH7.4, 150 mM NaCl, 3 mM 
EDTA and 0.05% N-P40) for 5 - 10 min, and then washing thor- 
oughly in Tris (10 mM, pH7.4) EDTA (3 mM). The resulting pel- 
leted material was used as the starting material for one- and two-di- 
mensional (isoelectric focussing and non-equilibrium pH gradient 
[26,27] gel electrophoresis. Gels were blotted onto nitrocellulose 
paper (0.45 pm, Schleicher and Schuell) for 1 h [28] and blocked 
with 0.05% TWEEN-20 in PBS overnight. Primary antibody incu- 
bations were carried out at room temperature for 1 h using anti- 
body-containing culture supernatants diluted 1: 5 (except for AEl, 
supernatant diluted 1: 20; KA4, ascites fluid diluted 1:300; 
KM4.62, commercial stock diluted 1: 1000 and anti-IFA, superna- 
tant diluted 1: 10) in expired unused tissue culture medium contain- 
ing 10% fetal calf serum (FCS) and 0.05% sodium azide. Blots were 
then washed extensively and rapidly in tap water (10 min at room 
temperature), incubated in a second antibody solution (rabbit anti- 
mouse immunoglobulins conjugated to horseradish peroxidase, 
DAKOPatts a/s, diluted 1: 100 in expired unused medium contain- 
ing 10% FCS) for 1 h at room temperature, washed copiously again 
in tap water (5 - 10 min), washed in PBS i- 0.05% TWEEN-20 + 
0.5% bovine serum albumin (BSA) for ten min, rinsed in tap water, 
then incubated in diamino benzidine (DAB; Sigma) substrate [0.5 
mg/ml DAB in PBS, with fresh solutions to .003% aqueous nickel 
sul 
P 
hate and .OOI% hydrogen peroxide (30 vol) added just before 
use for 1 - 5 min. Blots were stained for total protein content with 
India ink [29]. 
Immunohistochemistry Skin biopsies were obtained from nor- 
mal human volunteers or from surgical trimmings; other epithelial 
samples were obtained from surgical trimmings or from autopsies. 
Fetal material was obtained from the Royal Marsden Tissue Bank, 
London. Tissues were snap-frozen in liquid nitrogen; unfixed cryo- 
stat sections were stored at -70°C until used for staining. Antibody 
incubations and enzyme visualization procedures were as for im- 
munoblotting (above). Counterstaining was with Harris’s haema- 
toxylin and specimens were air-dried and mounted in DPX moun- 
tant (BDH). 
Selection of cDNA Clones by Expression Approximately 6 X 
lo5 plaque-forming units (pfu) of a cDNA Agtl 1 expression library 
constructed from human placental mRNA (Clontech) were 
screened with the monoclonal antibody LP2K. The screening pro- 
cedure of Young and Davis [30] was followed for the induction of 
fusion protein in lgtll and transfer of colonies to nitrocellulose 
filters (BA85,0.45 pm, Schleicher and Schuell). After washing the 
filters in PBS for 5 - 10 min, immunolocalization of clones express- 
ing keratin 19 fusion proteins was carried out following the anti- 
body incubation and washing procedures described above for im- 
munoblotting. Positive reactions were detected in 3 X 10e3 % of 
the colonies screened. Positive clones were checked with BA17 
(anti-keratin 19 monoclonal antibody), and purified clones were 
further checked for reactivity with other anti-19 antibodies as 
above. After several rounds of screening, pure bacteria 
samples were prepared. For each clone, a 15 cm plate o P 
hage DNA 
the Escheris- 
chia coli bacterial host strain Y 1090 was infected with approximately 
lo5 pfu of bacteriophage and the phage lysis allowed to proceed to 
completion; the plate was overlayed with buffer (100 mM NaCl; 
10 mM MgSO,; 50 mM Tris pH 7.0) at 4°C for 2 d. The overlay 
was then removed and spun in a caesium chloride equilibrium gra- 
dient at 55,000 rpm for 14 h. The bacteriophage band was recov- 
ered and spun in a two-step caesium chloride density gradient at 
35,000 rpm for 1 h. The bacteriophage band was extracted, dena- 
tured with formamide, and the DNA was precipitated with ethanol. 
The inserts from positive clones were also subcloned into the plas- 
mid expression vector pUR292 [31], and subsequent reactivity of 
multiple keratin 19-specific antibodies with the &galactosidase fu- 
sion proteins expressed in these constructs confirmed that the clones 
selected were indeed coding for keratin 19. 
Sequencing and Analysis of Human Keratin 19 Clones Two 
of the largest LP2K-positive agtll clones, APSE12 (1335 bp) and 
APSE21 (1394 bp), were chosen for further analysis. Purified insert 
DNA was self-ligated, sonicated into random fragments, blunt- 
ended and subcloned into the Smal site of M13mp9 and mp18 
[32,33], and sequenced by the dideoxy chain-termination method 
[34]. The majority of the sequence was covered by overlapping 
fragments and included sequence of the complementary strand; any 
uncertain areas were verified using oligonucleotide primers con- 
structed to regions within the sequence. The sequence of the PSE21 
clone provided the complete coding region including the initiating 
methionine and 32 bp of the 5’ untranslated region. Restriction 
enzymes were obtained from New England Biolabs. Calf intestinal 
alkaline phosphatase was obtained from Boehringer Mannheim. 
[a35S]ATP was obtained from Amersham International and deoxy- 
and dideoxynucleotriphosphates from Pharmacia. Computer analy- 
sis programs were used to assemble the cDNA sequence [35], pre- 
dicting amino acid sequence and subsequent protein structural con- 
formation [36,37]. Multiple sequence alignment and comparison of 
the rod regions of type I keratins were done manually. 
RESULTS 
Biochemical Characterization of Monoclonal Antibody 
LPZK Figure 1 shows that the monoclonal antibody LP2K reacts 
by immunoblotting consistently and specifically with a component 
of molecular weight 40,000 Daltons in the keratin pre 
identified as keratin I9 according to the numerical classi f! 
arations, 
cation of 
Moll et al [I]. Positive reactivity of LP2K with cell lines either by 
immunoblotting or by immunofluorescence is completely corre- 
lated with the presence of this low molecular weight keratin as 
detected biochemically. 
Immunohistochemical Reactivity of LPIK: Hair Follicles 
Immunohistochemical staining of the antibody LP2K on frozen, 
unfixed sections of a variety of body sites of normal skin indicated 
the presence of keratin 19 in hair follicles (Fig 2) in a defined zone of 
basal keratinocytes in the deep outer root sheath. These cells could 
be detected with all the antibodies to keratin 19, although BA16 
antibody staining was always weaker than the others. Positive cells 
were seen where the outer root sheath widens and the arrector pili 
muscle attaches to the hair follicle, below the sebaceous gland duct 
and below the follicle isthmus. These cells are thus located adjacent 
to the transition from epidermis-like differentiation in the follicle 
isthmus to a less well differentiated domain in the deep follicle 
(keratin 10 is only expressed in the upper infundibulum region and 
not in the lower portion [7]). They have the appearance of normal 
keratinocytes, cuboidal in shape and situated directly on the basal 
lamina, forming an integral part of the basal cell layer of the outer 
hair root sheath. Staining of basal and occasionally scattered supra- 
basal cells was seen sporadically from this point down to the hair 
bulb, but it was never seen in cells further out towards the skin 
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Figure 1. Specificity of monoclonal antibody LPZK for keratin 19 as dem- 
onstrated by immunoblotting. a and b: Specificity of LPZK immunoreactiv- 
ity only on the cell lines known to express keratin 19: (a) immunoblot and 
(b) protein stain of same blot using India ink. 1 = T47D (mammary carci- 
noma line), 2 = A431 (vulva1 carcinoma line), 3 = BT20 (mammary carci- 
noma line), 4 = PtKl (kidney cell line, marsupial origin), 5 = normal epi- 
dermis, 6 = MCF-7, and 7 = CAMA- (also mammary carcinoma lines). c 
and d: Immunoperoxidase localization of LPZK reacting with keratin 19 
only (c) on nitrocellulose blot of two-dimensional gel electrophoretic sepa- 
ration of MCF-7 breast carcinoma cell line keratins, and (d) protein staining 
of the same blot using India ink;pH> indicates direction of reducing pH or 
isoelectric point of proteins. Arrowheads show Mr (relative migration) of 
internal molecular weight standards keratins 8 (52.5 kD: upper, open arrow- 
head) and 18 (45 kD: lower, open arrowhead) and keratin 19 (40 kD: lowest, 
closed arrowhead). 
surface. Though few in number, the keratin 19-containing cells 
constituted a predictable feature of the hair follicle. 
In forearm hair follicles a small subpopulation of cells showed 
reactivity with LP2K [7]. In the hair follicles from scalp, scrotum, 
and eyelid skin the same type of staining was seen (Fig 2), although 
the keratin 19-containing zone was much more extensive in the 
large hair follicles of the scalp than in forearm. In non-scalp skin, 
positive groups of cells sometimes appeared as little knobs protrud- 
ing into the connective tissue from the otherwise smooth cross-sec- 
tional profile of the follicle. 
Keratin I9 is present in human hair follicles at all stages of devel- 
opment. Hair bud s and hair pegs from fetal skin of 14 weeks gesta- 
tional age express keratin I9 in all their cells (Fig 3~); as the follicles 
grow, the staining becomes progressively restricted until the adult 
pattern is attained. Figure 2cJ shows staining by BA16 of a small 
cluster of cells in the appropriate position 18-week fetal skin hair 
follicles; this antibody was previously interpreted as not staining 
hair follicles [7,12]. Th e 1 ower swelling on the side of the develop- 
ing follicle (containing the positive cells) will become the attach- 
ment site of the smooth muscle, while the upper swelling (keratin 
19 negative) will form the sebaceous gland. 
Basal cells showing LP%K-positive reactivity for keratin 19 were 
unstained by monoclonal antibodies specific for keratin 8 (LE41) or 
18 (LE61), distinguishing them unequivocally from Merkel cells, 
which do react with these and other antibodies to keratins 8 and 18 
[7,38]. 
Immunohistochemical Reactivity of LPZK: Other Tissues 
In common with the staining in the hair follicles, all the places 
where keratin 19 was detected were areas where epithelial cells 
expressing different keratin phenotypes coexisted in close proxim- 
ity. Our results regarding tissues expressing keratin 19 were com- 
pletely consistent with previous reports [12]. Positive reactivity was 
observed on sweat gland and mammary gland ductal and secretory 
cells, bile ducts, gastrointestinal tract, and homogeneously through 
all cell layers in bladder urothelium, which expresses a particularly 
complex profile of keratins. Basal layer keratinocytes were stained 
with varying degrees of heterogeneity in oral epithelia, ectocervical 
epithelium [39], including endo-ectocervical junction and oeso- 
phagus. In the oral epithelia, basal cell staining with LP2K was 
strikingly correlated with areas of variable keratin phenotype of the 
suprabasal cells [40,41] (Fig 3b). Hepatocytes and interfollicular 
body epidermis were negative, but patches of positive basal cells 
were often observed in nipple skin, close to the ducts (Fig 3~). Extent 
of nipple skin staining was highly variable on an individual level. 
Keratin 19-positive basal cells in nipple skin were not stained with 
antibodies to keratins 8 and 18 (LE41,LE61), again distinguishing 
them from Merkel cells and also from the cell type seen in Paget’s 
disease [23,42]. In “mixed” epithelia such as gland ducts (sweat 
gland, mammary gland), where luminal and basal cells appear to 
have distinct keratin phenotypes [43], staining was observed in both 
cell layers but most strongly in the luminal cells, which are true 
simple epithelial cells. Patches of keratin I9-negative luminal cells 
have been reported to occur beyond the branch points of mammary 
gland ducts in the region where pluripotent progenitor cells might 
be predicted [8]. 
In all samples examined, LP2K staining was compared with that 
of at least two other antibodies reported as being specific for keratin 
19, and no discrepancies were observed other than quantitative 
ones: culture supernatants containing LP2K gave more intense 
staining than BA16, but usually less than A53-B/A2. No useful 
staining with LP2K was obtained if tissues were fixed in formalde- 
hyde. 
Identification and Sequencing of cDNA Clones for Keratin 
19 A number of J.gtl 1 clones expressing fusion proteins reactive 
with LP2K and other antibodies to keratin 19 were identified and 
purified from the placental cDNA library, using an immunoperoxi- 
dase staining protocol that was originally devised for immunoblot- 
ting from SDS polyacrylamide gels. All pure clones were checked 
for their reactivity with several other monoclonal antibodies to 
keratin 19, either on the modest amounts of &galactosidase fusion 
proteins expressed by the 1gtll clones or on the high levels of 
fusion protein expressed by the pUR plasmid constructs, which 
supported their identification as true keratin 19-encoding clones. 
Sequencing of the clone PSE21 gave the full-length coding se- 
quence for human keratin 19 [I4], as became apparent when the 
predicted amino acid sequence for which it coded was deduced, as 
shown in Fig 4. 
The sequenced keratin 19 cDNA is 1394 bp long (Fig 4), con- 
taining an open reading frame of 1200 bp starting with the initia- 
tion codon ATG at nucleotide 33 and ending with the termination 
codon at nucleotide 1233. The ATG is in an appropriate context for 
710 STASIAK ET AL THE JOURNAL OF INVESTIGATIVE DERMATOLOGY 
e 
Figure 2. Keratin 19 is expressed in hair follicles. Unfixed frozen sections of hair follicles through attachment point of arrectorpili muscle, below isthmus, 
where inner root sheath is still substantial. Stained by immunoperoxidase with LP2K (a,b,e) or BA16 (c,d): reaction product is black. 0: Scrotum skin 
(transverse sections: patchy staining); b: Scalp ( o bl’q I ue section: extensive positive zone); c,d: foetal body skin at 18.5 weeks gestation, longitudinal section seen 
with phase contrast (c) and bright field (d) microscopy: interfollicular basal cells are positive (negative in adult) and most of the follicle is negative, but the few 
cells in the lower protrusion (arrow) which will form the site of arrector pili attachment are in the same relative position as the positive cells seen in adult 
follicles. e: Eyelid skin with cross-sections through two follicles. With (CZ) or without (b-e) h aematoxylin counter stain. (o: outer root sheath, i: inner root 
sheath; Scale bars: 100 pm.) 
the start of translation [44]. The 159 bp 3’ untranslated region in- 
cludes a 34 nucleotide poly-A tail. A putative polyadenylation signal 
AATAAA lying in the consensus sequence CCAATAAAAATT 
[45] is present 17 bp upstream of the start of the poly-A tail. This 
1394 bp cDNA clone is smaller than the expected mRNA size of 
1585 bp reported by Eckert and Green [46] and the approximately 
1.5 kb size mRNA species with which the PSE21 clone hybridizes 
in Northern blot analysis of MCF-7 RNA (data not shown); ob- 
viously this clone does not include the complete 5’ untranslated 
region and probably does not have a complete poly-A tail. 
The open reading frame codes for a 400 amino acid protein, 
including the initiating methionine. The sequence predicts a pro- 
tein of 44.1 kD molecular weight, which is larger than the esti- 
mated molecular weight of 40 kD as determined by electrophoretic 
mobility on SDS polyacrylamide gel electrohoresis. It is a typical 
member of the type I intermediate filament family, with a non-heli- 
cal amino-terminal head domain and an alpha-helical rod domain, 
but as was found for the homologous bovine protein the tail region 
is abnormally short. Only 13 amino acids occur beyond the 
TYR[X]LLEG[Q/,] q se uence, which marks the end of the helical 
domain in other intermediate filaments. 
Secondary structure predictions from the amino acid sequence 
show the consensus a-helical rod domain from amino acid positions 
83-387. It is possible that the helical configuration starts even 
further towards the amino terminus at position 74 and could extend 
right to the carboxy-terminal end of the sequence. The whole of 
this region shows the predominance of hydrophobic residues at the 
first and fourth positions of each seven residues, which is character- 
istic of proteins that form coiled-coils [47] due to the hydrophobic 
“backbone” of the coiled monomer. There are two indications, 
apart from the linkers Ll and L2, of irregularities in this heptad 
repeat pattern around two phenylalanine residues at amino acid 
positions 271 and 331. The first one following position 271 may be 
accomodated as a couple of wider turns in the helix, or it may 
indicate the presence of a helix break or linker region (linker “L2” 
[48]) from positions 259 - 274. The second irregularity, around po- 
sition 33 I, is probably the polarity reversal feature that appears to be 
well conserved among intermediate filaments. 
Finally, analysis of the predicted amino acid sequence with the 
PCGENE program indicated the occurrence of a possible glycosyla- 
tion site on human keratin 19 at amino acid position 393. 
The sequence for human keratin 19 recently published by Eckert 
[I51 is virtually identical to ours. The apparent discrepancies be- 
tween his and ours as first published [14] can probably be explained 
as sequencing errors. Figure 4 presented here has changes at posi- 
tions 268-273 bp and 1056- 1057 bp from that published pre- 
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Figure 3. Keratin 19 expression in transitional regions. Immunoperoxidase 
staining with LPZK, reaction product appears black [unfixed frozen sections 
with (a) or without (b,c) haematoxylin counterstaining]. a: Foetal body skin 
of 14 weeks gestation (specimen folded over so two epidermal surfaces face 
each other); extensive staining seen strongly in hair follicle pegs, basal cells, 
and periderm layer, weak to moderate in intermediate layers. b: Oral sulcular 
epithelium (see Refs 42 and 43); patchy staining of basal cells. c: Variable 
patchy staining of basal cells often seen in epidermis of nipple; in some 
individuals this was a continuous basal layer. (h: hair follicle pegs; Scale bars: 
100 pm.) 
viously [14], but maintains differences from Eckert’s sequence at 
positions 503 bp and 1080- 1082 bp. The virtual identity of the 
two sequences arrived at independently and from different tissue 
sources (i.e., our from simple epithelium of placenta and Eckert’s 
from a stratified squamous epithelium-derived cell line) argues for 
the presence of only one active gene for keratin 19 in Homo sapiens. 
Sequence Analysis 
(i) Comparison with &BovineHomologue: Figure 5 shows acompar- 
ison of the bovine and human keratin 19 amino acid sequences. As 
has been found previously when other homologous intermediate 
filament sequences have been compared across species, the similar- 
ity of the two sequences is extremely high, with 86.3% identity in 
the head region (amino acids 1 - 73 with respect to human keratin 
19) and 91% identity in the alpha-helical rod region overall (amino 
acids 74 - 387). At the DNA level, the 3’ untranslated region is also 
highly homologous with that of bovine keratin 19, showing 73% 
identity (not shown): similarity between the 3’ untranslated regions 
of homologous genes across a species barrier has been noted before 
[49]. However, great divergence is seen when the sequences of the 
tail domain are compared, because 8 out of the 13 amino acids 
occurring beyond the conserved rod domain termination sequence 
TYR[X]LLEG[Q/,] are non-identical. Within any I3 amino acid 
stretch over the whole sequence comparison of bovine and human 
keratin 19, there are never less than nine identical amino acids (i.e., 
69% identity); this divergence is thus statistically significant. 
(ii) The Non-Helical Head Domain: Although the central a-helical 
rod domain of intermediate filament proteins is well conserved 
within each intermediate filament class, the selection pressures act- 
ing upon the non-helical head and tail domains appear to be differ- 
ent, because non-helical domain sequence features are often shared 
between type I and type II keratins coexpressed in the same tissue 
[50,5 11. Therefore, in order to try and assess the relatedness between 
human keratin 19 and the other type I keratins, the helical and 
non-helical domains are considered separately. 
The 73 amino acid long head domain of human keratin 19 con- 
tains a number of glycine-rich stretches, for example “GGYGG- 
GYGG,” together with many serine residues. Glycine and serine 
alone account for 52% of amino acids in this domain. Glycine- and 
serine-rich repeats have been noted in the termini of a number of 
keratinocyte keratins, expressed in stratified epithelia, such as 
human keratin 14 [52], the mouse keratin 10 homologue [53], and 
Xenopus laevis larval epidermal keratins DG81.Al and DG81.B2 
(54). In contrast, very few such repeats are present in the non-helical 
domain sequences of type II keratins 7 [55], and 8 [56,57], and in 
Type I keratin 18 [58-601, w ic h’ h 
expressed in simple epithelia. 
are the three keratins specifically 
(iii) The Central cx-Helical Rod Region-Areas of Conservation: 
Within the rod domain, keratin 19 shows significant homology 
only with the other type I keratins. The great number of (mostly 
partial, mostly C-terminal) sequences of type I keratins that have 
been identified allows an analysis of the degree of sequence conser- 
vation between the different subdomains of the type I keratin 
helices, shown in Fig 4. The consensus boundaries of the helical 
subdomains have been taken as amino acid positions 83 - 116 (helix 
lA), 126-225 (helix lB), and 245-387 (helix 2), inclusive with 
respect to human keratin 19, based on Geisler and Weber’s analysis 
of several kinds of intermediate filaments [61] and our interpreta- 
tion of type I keratin sequences. Thus the helical rod domain for 
this analysis begins with the highly conserved peptide 
TMQ[X]LNDRLA[X]YL and ends with the shorter conserved 
peptide TYR[X]LLEG[Q/,]. 
From this figure two points may be made. First, the keratins 
which are most homologous to human keratin 19, apart from the 
nearly identical bovine keratin 19, are the human keratinocyte kera- 
tins 14,15 [65], and 16 [66] (f ormerly thought to be keratin 17), and 
the mouse homologue [63] of h uman keratin 13, suggesting a high 
degree of relatedness in spite of the species differences. 
Second, the divergence of keratin 18 from all the keratinocyte 
keratins, as well as from keratin 19, is strikingly apparent from the 
consistently low scores of the human [58] and mouse [60] keratin 18 
sequences. 
DISCUSSION 
It is clear that human keratin 19, like the homologous bovine pro- 
tein, does not have a non-helical C-terminal domain in the sense 
that other keratins do. When the bovine and human species se- 
quences are compared, there is a dramatic loss of any significant 
homology over the last 13 amino acids extending beyond the con- 
sensus helical domain termination sequence. Because the rest of the 
sequence is particularly highly conserved, this divergence indicates 
either a reduction of selection pressure on this stretch, or that this 
region of the polypeptide has a completely different sequence re- 
quirement in the two species. The latter explanation seems unlikely 
because no such divergence has been seen in any other pair of ho- 
mologous keratins sequenced from different species, and the non- 
helical tail domains are usually no less well conserved than the 
N-terminal domains. We believe the divergence is strong evidence 
for absence of function. 
Although it is obvious that the helical rod domain of the polypep- 
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56 
cGa;GGTlQXCcGTccGTCTCCGCCKGcc &E ACT TCC TAC AGC TAT 'XX CAG 
Met Thr 5er Tyr Ser Tyr Arg Gln 
677 704 
CTGAAG GAA W CTG GCC TAC CTG AAG AAGAAC CAT GAG GRG GAAATC AGT ACC 
La Lys Glu Glu Leu Ala Tyr Leu Lys Lys Asn His Glu Glu Glu Ile SW Thr 
* 208 t t . . I 
83 110 
TCC TCG Kc AcG TCG TK TTC GGA CCC CTG GGC GGC GGC TCC GTG Cm T'rI = ->I 731 758 
Ser Ser Ala Thr Ser Ser Phe Cly Gly Leu Gly Gly Gly Ser Val Arg Phe Gly CI'GAGG CGc CAA GTG GGA GGC CAG G'IC AGT GTG GAG GTG GAT TCC GCT CCG CGC 
9 Leu Arg Gly Gln Val Gly Gly Gin Val Ser Val Glu Val Asp Ser Ala Pro Gly 
* 226 
137 164 
KG GGG GTC GCT 'ITT CGC GCG CCC AGC ATT CAC GGG GGC TCC GGC GGC CGC GGC 
Pro Gly Val Ala Phe Arg Ala Pro Ser Ile His Gly Gly SW Gly Gly Arq Gly 
27 
191 218 
GTA TCC GTG TCC TCC GCC CGC TTT GCG XC TCG TCC KC TCG GGG GE TAC GGC 
Val Ser Val Ser Ser Ala Arg Phe Val Ser Ser Ser Ser Ser Gly Gly Tyr Gly 
44 
245 272 
GGC GGC TAC GCC a;c GTC =GACC GCG TCC u\C GGG CTG CPG GCG GGCAAC GAG 
Gly Gly Tyr Gly Gly Val ku Thr Ala Ser Asp Gly Leu Leu Ala Gly Am Glu 
63 
I-Helix 1A -> 299 326 
AAG CTA ACC AX CAG AAC CTC AAC GAC CGC mG GCC ‘EC TAC CTG GAC AAG GTG 
Lys Leu Thr Met Gin As" Leu As" Asp Arg Leu Ala Ser Tyr Leu Asp Lys Val 
81 . t * ?? t 
353 -->I 
CGC GCC CTG GAG GCG GCC MC GGC GAG CTA GAG GTG MG ATC CGC GAC Tffi TAC 
Arq Ala Leu Glu Ala Ala As" Gly Glu Leu Glu Val Lys Ila Arq Asp Trp T,'r 
99 ?? t t ?? ??
407 I-Helix 1B -> 434 
CAGAAG CAG GGG CCT GGG CCC TCC CGC GK TACAGC QaC TAC TACACGACCATC 
Gln Lys Gln Gly Pro Gly Pro Ser Arg Asp Tyr Ser His Tyr Tyr Thr Thr Ile 
117 . t t 
461 488 
CAG GAC C'TG CGG GWAAGATT CTT GGT CCC ACC ATT GAG AAC TCCAGGATT GTC 
Gin Asp Leu Arg Asp Lys Ile Leu Gly Ala Thr Ile Glu As" Ser Arg Ile Val 
135 ?? ?? t t ??
515 542 
Cn; CAG ATC GAC MC WC CGT CTG GCT GCA GAT GAC TI’C cu\ ACC AAG TTT GAG 
Leu Gin Ile Asp As" Ala Arq Leu Ala Ala Asp Asp Pha Arq Thr Lys Phe Glu 
153 f f t ?? ??
569 596 
ACG GAA CAG GCT CTG CGC ATG AGC GTG GAG GCC GAC ATC MC GM: CT(; CCC AGG 
Thr Glu Gln Ala Leu Arq Met Ser Val Glu Ala Asp Ile As" Gly Leu Arg Arq 
171 ?? f . . . 
623 650 
GE CTG GAT GAG CTG ACC CTG GCC AGG ACC GAC CTG GAG An; CAG ATC GAA GGC 
Val Leu Asp Glu Leu Thr La Ala Arq Thr Asp I.eu Glu Met Gin Ile Glu Gly 
189 * . t . t 
I-Helix 2 -> 785 812 
ACC GAT CTC GCCAAGAM CTGAGT GACATG CGA AGC CAA TAT GAG GTC ATG Gee 
'Ihr Asp ku Ala Lys Ile Leu Ser Aap Met Arq Ser Gln 'I,'r Glu Val Met Ala 
243 ' t . . 1 
839 866 
GAG CAGAAC ar;AAG GAT GCT GAA GCC TGG TTC ACC AGC CGG ACT u\A GAA TTG 
Glu Gin As" Arq Lys Asp Ala Glu Ala Trp Phe Thr Ser Arg Thr Glu Glu Leu 
261 ?? ?? *A+ ?? ??
893 920 
MC CGG GAG ‘XC GCT GGC CAC ACG GAG CAG CTC CAGATG AGC AGG TCC GAG GTT 
As" Arg Glu Val Ala Gly His Thr Glu Gin Leu Gln Met Ser Arg Ser Cl" Val 
279 t * ?? t * 
947 974 
ACT GAC 'XC CCG CCC ACC CZT CAG GGT CTI GAG ATT GAG CTG CAG TcA CAG Ci"G 
Thr Asp Leu Arg Arq Thr LQU Gin Gly Leu Glu Ile Glu Leu Gln Ser Gin Leu 
297 ?? t I . t 
1001 1028 
AGC ATGAAA Ccp GJX TX GAA GACACA CTG GCA GAAACG GAG GCG CGC mT u;A 
Ser Met Lys Ala Ala L.eu Glu Asp Thr Leu Ala Glu Thr Glu Ala Arg Phe Gly 
315 ?? t . ?? ‘A 
1055 1082 
GCC UIG CTG CCG CAT ATC CAG GCG CTG ATC AK GGI ATT GAA GCC CAG CTG GCG 
Ala Cl" Leu Ala HUB Ile Gl" Ala Leu Ile Ser Gly Ile Glu Ala Gin L.eu Ala 
333 ?? * * t f 
1109 1136 
GAT GTG CGA GlX GAT Am GAG CGG CAG AAT CAG GAG TAC CAG CGG CTC ATG GAC 
Asp Val Arg Ala Asp Ser Glu Arq Gin Aan Gin Glu Tyr Gin Arg Leu Met Asp 
351 ?? t * f . 
1163 1190 
ATC AAG TCG CGG Cl% GAG CAG GAG ATT GCC ACC TAC CGC AGC CTG CTC UIG GGA 
Ile Lys SW Arq Leu Glu Gin Glu Ile Ala Thr Tyr Arq Ser Leu Leu Glu Gly 
369 ?? t t * ??
-> 1217 1247 
CAG GAA GAT CAC TACAACAAT TTG TCT KC TCC AAG GTC CK~GGCAGCAGGCTC 
Gin Glu Asp His Tyr As" As" Leu Ser Ala Ser Lys Val ku 
?? ?? R * 400 
Figure 4. cDNA sequence of human keratin 19 with amino acid translation. Anotated to show the following: predicted a-helical regions (coil lA, coil lB, 
coil 2) with arteriskr below residues at key positions in heptad repeat; putative glycosylation site (L!) at amino acid position 392; probable loops or 
discontinuities in helix (A) around amino acid positions 270 and 330. Initiation codon, stop codon, and polyadenylation signal are underlined. 
Figure 5. Amino acid sequence homology between bovine and human 
keratin 19. Identical residues: vertical bars: conservative substitutions: vertical 
dash. Helical domains are indicated by boxec (IA, IB, 2). Dashed box outlining 
post-helical domain terminal extension: homology is 90% in the helix and N- 
terminal head region, but drops to 33% (only 5/13 shared residues) after the 
TYRSLLEGE consensus helix termination peptide. 
tide must form the fundamental construction unit of intermediate 
filaments, little else is known about specific domain functions. Bio- 
chemical cleavage studies indicate that the amino terminal non-he- 
lical domain is required, together with the a-helix, for correct fila- 
ment polymerization, but that the carboxy-terminal domain is not 
[72]; keratin 19 appears to polymerize normally, at least with kera- 
tin 8 [I3]. It has been suggested that the non-helical domains of 
intermediate filaments may extend laterally from the body of the 
filament, and there is good evidence that this is the case for the 
carboxy-terminal domain of neurofilament proteins [73]. Sequence 
characteristics of head and tail domains can be shared between type 
I/type II pairs of keratins that are coexpressed in the same tissue, 
while their helical domain sequences bear little relationship to each 
other [55,51], so that some aspect ofthe tissue specificity of keratins 
is reflected in the C-terminal domain. Extending from the filament, 
and with minimal involvement in polymerization, the tail domain 
could be a prime site for tissue-specific interactions with other cyto- 
plasmic components. 
Keratin I9 may have been specifically conserved for some pur- 
pose dependent u 
main. If so, the act that there only appears to be one “tail-less” ? 
on the absence of the carboxy-terminal tail do- 
keratin (because there is no equivalent type II protein) implies that 
either a putative tail-determined function can be abrogated by the 
deletion of the domain from only one of the two keratin types in a 
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heteropolymer (in which case the two tail domains may function by 
specifically interactng with each other), or the function of the tail 
domain in type I keratins is different from their function in type II 
keratins. 
Keratin 19 is Closer to the Keratinocyte Keratins than to 
Simple Epithelial Keratin 18 Comparing the amino acid se- 
quences of the helical rod domains from a total of 20 type I keratins 
that have been fully or partially sequenced to date (Fig 6), it is clear 
that human keratin 19 is very closely related to the keratins ex- 
pressed by stratified epithelia, whether the comparison is made over 
the short, highly conserved coil 1A or the long, more divergent coil 
2. The homology with keratin 18 is strikingly lower. This is notable 
because keratin 19 is usually regarded as one of the keratins charac- 
teristically expressed by simple epithelia [4,8]; clearly, keratin 19 
should rather be thought of as related to the keratinocyte keratins. 
Divergences between keratin 18 and other type I keratins were 
noticed by Singer et al [60], as was a lack of expected obvious simi- 
larity between keratins 19 and 18 by Bader et al [13]. The diver- 
gence of the whole group of keratinocyte keratins from the simple 
epithelial hallmark keratin 18 suggests that keratin 18 may even 
belong to a different subgroup, and may possibly be from a more 
distant, probably older, evolutionary stock. 
The degree of homology of human keratin I9 with mouse kera- 
tin 13 is considerable in view of the species difference. Once the 
sequence of human keratin 13 has been determined, the homology 
between keratins 13 and I9 may well be found to be even higher. 
This may be relevant because keratins I9 and 13 are often expressed 
in the same tissues, although at different stages of differentiation 
because keratin 19 is observed in basal cells and keratin I3 in supra- 
basal cells. Both these keratins are dramatically inducible by reti- 
noids [46], at least in tissue culture situations. Both the human 
keratin 19 shown here and the mouse keratin 13 [64] have potential 
glycosylation sites, the one in keratin 19 at amino acid position 393 
(Fig 4) and three in mouse keratin 13 at amino acid positions 290, 
291, and 296. Human keratin 13 is known to be glycosylated in vivo 
[74,75], and from its behaviour on gel electrophoresis it seems likely 
that mouse keratin 13 is also. It is not known whether or not keratin 
19 is glycosylated in vivo; neither is it known what the function of 
glycosylation of keratins might be. 
Tissue Distribution of Keration 19 Expression Keratin 19 is 
the only keratin of the 29 separate human keratin species identified 
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to occur in both simple and stratified squamous epithelia in signifi- 
cant amounts and under normal circumstances [ 1,5,7 - 121. Keratin 
19 has been detected biochemically in a large number of different 
epithelial tissues [5], and in many of these tissues the exact cells 
which express keratin 19 have now been identified using monospe- 
cific monoclonal antibodies [6,7,12]. Some of these tissues are illus- 
trated in Figs 2 and 3. Considering the pattern of expression within 
tissues it appears to be the case that wherever two different epithelial 
cell phenotypes coexist in close proximity to one another, such that 
they may have arisen from a common progenitor cell pool, keratin 
19 is abundant. Either two morphologically distinct epithelia abut 
(such as the endo-ectocervical junction), two different cell types 
coexist within the same epithelium (such as the “mixed” epithelia 
of glands/gland ducts), or cells with two diverse differentiated ker- 
atin phenotypes can be seen in close apposition (as seen in oral 
epithelia). Furthermore, where the tissue location of the progenitor 
compartment is known, this location frequently appears to coincide 
with the distribution of keratin 19: it is in the basal cell layer that 
keratin I9 is expressed rather than in the committed differentiating 
suprabasal compartment. 
The differentiation versatility, or instability, of cell populations 
associated with keratin 19 expression is particularily apparent in the 
following locations. Keratin 19 is widely expressed in oral epithelia, 
overlapping the many transitional zones. It is found heterogen- 
eously in patches of basal cells in the sulcular (tip of gum) epithe- 
lium down to the gingival epithelium [42,43]: non-cornifying sul- 
cular epithelium expresses keratins 4 and 13, but adjacent cornifying 
gingival epithelium expresses keratins l/2 and 10. During develop- 
ment of human epidermis, keratin 19 is strongly present in the basal 
layer and periderm, and weakly in suprabasal layers, at 14 weeks 
(Figure3) [7,76]: p b 1 11 su ra asa ce s simultaneously express keratins 13 
and 10 [7,10,76] at this time (thus keratin 19 expression is not 
limited to keratin lo-negative regions). The mammary glandular 
epithelium consists of 2 distinct epithelial cell types with different 
keratin phenotypes [43]: expression of keratin 19 is homogeneous in 
the luminal cells of most, but not all, parts of the gland [8]. The 
nipple is the site of the junction of mammary gland ducts with the 
epidermis, and thi s epidermis expresses keratin 19 in patches of basal 
cells in an individually variable manner (Fig 3). Keratin 19 also 
appears in the basal cells of the ectocervix [39]. Two phenotypic 
variations are identifiable here: first the transition from endocervix 
(simple epithelium plus basal reserve cells) to ectocervix (stratified 
squamous epithelium), and second the variations in keratin pheno- 
Figure 6. Relatedness of rod domain sequences of other type I keratins to human keratin 19. Expressed as percentage (of available sequence) of amino acids 
(a(I) identical to human keratin 19 sequence. Consensus helical domain boundaries were as indicated in Fig 3. Penalties were included for gaps (ranging from 
l-l 1 aa) required to obtain an optimal alignment, but not for additional blocks of 4-13 aa in the sequence compared to keratin 19. Bol9: bovine homologue of 
keratin 19(13); Hu14: human keratin 14(52);Bo14: bovine keratinVI1, putative homologue ofhumanK14 (only 16 aaofhelix2) [62];Mol4B: mouse50 kD 
basal-expressed (only 31 aa of helix IA); Mol4S: mouse 50 kD basal- and suprabasal-expressed (only 44 aa of helix 2), two keratin 14 homologues [63]); 
Mo13: mouse putative keratin 13 homologue (641; Hul5: human keratin 15(65); Hu16: human keratin 16 (formerly thought to be keratin 17) [66]; Mol6: 
putative mouse homologue ofkeratin 16 [63]; HulO: human keratin IO [67];B010: b 
mouse, putative homologue of human KIO [53]; Hul8: 
ovine keratin Vlb, putative homologue of human KlO/Kll [68]; MolO: 
h uman keratin 18 [58]; Mol8: mouse END0 B, or homologue of human K18 [60]; Xe70: Xenopus 
Levis XK70 pre-metamorphic epidermal keratin [69]; Xe81Al and Xe81B2: X. Levis pre-metamorphic keratins [54]; XeEp: X. laevis epidermal keratin (only 
100 aa of helix 2). [70]; Sh8c: sheep wool keratin 8c [71]. 
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type seen in the suprabasal cells of the ectocervix (patches of supra- 
basal cells expressing keratins 10/l 1 have been identified by immu- 
nohistochemistry [39]). 
The observation (Fig 2) that in skin there exists a keratin 19-posi- 
tive subpopulation of cells in the hair follicle outer root sheath is of 
interest in view of the suggestion that a potent stem cell population 
may exist within the hair follicle [77]. It is known that skin damage 
to below the level of the hair follicles is much slower to regenerate 
than shallower damage where hair follicle bases remain [78,79]. 
Hair follicles had originally been reported as not containing keratin 
19 as assayed biochemically [16,17], although later immunohisto- 
chemical investigations indicated that there probably was keratin 19 
in follicles [7,12]. Earlier negative results were probably due to 
sampling artifacts. In tissue culture keratin I9 is expressed in most 
epithelial systems [1,3,5,10,19], and this is certainly a situation 
where drift is observed in keratin expression. In view of the induci- 
bility of keratin I9 by retinoids [46], though, it is difficult to inter- 
pret appearance of keratin I9 in tissue culture in the context of in 
situ differentiation. 
Keratin 19 and the characteristic patches of keratin 19-negative 
cells that are often observed where keratin I9 is expressed have 
tentatively been associated with the presence of stem cells [8]. The 
lack of keratin I9 over extensive regions of body skin such as inter- 
follicular epidermis makes it unlikely that keratin I9 is directly 
indicative of all stem cells, agreeing with Bartek et al [8]. Our 
observations, however, do suggest that there is a particular zone of 
interest, with respect to skin differentiation and regeneration, in the 
deep outer hair root sheath that warrants closer observation. The 
trend of the histochemical observations, towards more extensive 
detection of keratin I9 in the early stages of differentiation and of 
keratin I9 expression in regions of labile differentiation, does sug- 
gest at least that pluripotent progenitor cells may reside within the 
epithelial locations harboring keratin 19-positive cells. Keratin 19 
expression therefore could also indicate the location of particularily 
transformation-sensitive populations of cells. 
Possible Function of Keratin 19 Both Bader et al [ 131 and Eck- 
ert [ 151 have interpreted the presence of an in-register extension of 
the helix as indicating that keratin 19 reflects the more primitive 
state of an ancestral keratin from which other keratins subsequently 
evolved, because they argue that the good-in register match of the 
extension would be less likely to arise randomly than to reflect a 
primary condition that was subsequently lost. However, a-helicity 
is the most common structural conformation found in proteins, and 
an a-helix might be selected as a way of compacting any acquired 
irrelevant C-terminal peptides out of the way if the function of 
keratin I9 depends positively on having no post-helical domain. 
Thus it is not improbable that any recently-acquired post-helical 
extension might evolve as an a-helix. 
One good reason for arguing that keratin 19 is not the most 
primitive keratin is the strong similarity it bears to the keratins of 
stratified epithelia, which are structurally more elaborate than sim- 
ple epithelia and arise later in development. If keratin 19 is in any 
sense an ancestral keratin, it can only be ancestral to some of the type 
I keratins of stratified epithelia. The simple epithelial keratin 18, 
which is the earliest embryonic type I keratin, appears to be of a 
separate and probably older stock. 
A hypothesis that would link the tissue distribution pattern with 
the structural absence of a tail domain would be that keratin I9 has 
been conserved for its ability to act as a neutral keratin in terms of 
differentiaion. Keratin 19 is fully competent at polymerization and 
thus probably can integrate into the tonofilament network funda- 
mental to the structure of an epithelium, but it may not fully restrict 
the cell expressing it to differentiate along either or any available 
pathway if it lacks the (as yet unidentified) tail-specified differentia- 
tion function. Where keratin 19 is expressed in simple epithelia 
there is at present little information regarding the temporal se- 
quence of expression of additional keratins, but keratin-19-express- 
ing simple epithelia appear to be potentially heterogeneous. The 
differentiation-specific keratin pairs of stratified epithelia are ex- 
pressed once the cells have left the basal layer, but among these 
suprabasal keratins the type II member of each pair is often, if not 
always, expressed before its type I keratin partner [80,81] and can be 
detected in the basal layer. Presence of keratin I9 in the progenitor 
compartment of complex epithelia may allow a delay in expression 
of the second (type I) keratin by polymerizing with, and stabilizing, 
any early-synthesized type II keratins. Assuming that the tissue-spe- 
cific characteristics of a particular keratin filament type will only be 
realized when both members of the keratin pair are copolymerized, 
delayed synthesis of only the type I member of the pair could post- 
pone committment to differentiation as effectively as delaying both 
keratins. The complex formed between any given type II keratin 
and keratin 19 would be predicted to be of consistently lower affin- 
ity than the complex formed between this type II keratin and its 
specific type I partner, so that the appropriate type I keratin could 
always compete away the keratin 19 as the cells differentiated. A 
likely function for the tail domain, therefore, would be to provide 
high affinity reinforcement of the specific pair heteropolymer com- 
plex formation. 
This role for keratin 19 as a “switch” keratin could be a mecha- 
nism for suspending post-stem cell amplifying cells in a flexible 
state of differentiation, pending local demand for one or other cell 
type. Such an additional level of “decision making” in the regula- 
tion of differentiation within complex epithelia may in fact be es- 
sential for maintenance of tissue homeostasis within mixed cell 
populations or across boundaries. The possible existence of a keratin 
phenotype that is permissive or indicative of a labile state of differ- 
entiation may also have clinical implications, in the potential vul- 
nerability to transformation of such cells. 
Wegratefully acknowledge the assistance ofDr. Josephine Nalbantoglu for advice on 
sequencing, Dr. John Youngfor advice on bacteriophage lambda DNA preparation, 
Dr. Robert Oshima for helpful d’ mussions. We also thank all who let us use their 
antibodies {Dr. UweKarstenfor A53-B/AZ, Dr. Jiri Bartekfor BA16 and BA17, 
Dr. RayNagleforKA4 and Dr. Tung-Tien Sunfor AEI) andMessrs. John Gilbert 
and George Elia for cutting the frozen sections. Since this manuscript was written, 
Heid et al [Dt@entiation 37:137- 157, 19881 reported variablestaining of kera- 
tin 19 in hair follicles of human scalp using monoclonal antibody A53-B/AZ 







Moll R, Franke WW, Schiller DL, Geiger B, Krepler R: The catalog of 
human cytokeratins: patterns of expression in normal epithelia, 
tumors and cultured cells. Cell 31:11-24, 1982 
Heid HW, Moll I, Franke WW: Patterns of expression of trichocytic 
and epithelial cytokeratins in mammalian tissues. II. Concomitant 
and mutually exclusive synthesis of trichocytic and epithelial cyto- 
keratins in diverse human and bovine tissues (hair follicle, nail bed 
and matrix, lingual papilla, thymic reticulum) Differentiation 
37:215-230, 1988 
Wu Y-J, Rheinwald JG: A new small (40kd) keratin filament protein 
made by some cultured human squamous cell carcinomas. Cell 
25:627-635, 1981 
Sun T-T, Eichner R, Schermer A, Cooper D, Nelson WG, Weiss RA: 
Classification, expression, and possible mechanisms of evolution of 
mammalian keratins: A unifying model. In: Levine AJ, Vande 
Woude GF, Topp WC, Watson JD (eds). Cancer Cells I, The 
Transformed Phenotype. Cold Spring Harbor Laboratory, Cold 
Spring Harbor, 1984, pp 169- I76 
Quinlan RA, Schiller DL, Hatzfeld M, Achtstatter T, Moll R, Jorcano 
JL, Magin TM, Franke WW: Patterns of expression and organiza- 
tion of cytokeratin intermediate filaments. Ann NY Acad Sci 
455:282-306, 1985 
Bartek J, Durban EM, Hallowes RC, Taylor RC, Papadimitrou J: A 
subclass of luminal epithelial cells in the mammary gland defined by 
antibodies to cytokeratins. J Cell Sci 75:17-33, 1985 
Lane EB, Bartek J, Purkis PE, Leigh IM: Keratin antigens in differen- 
tiating skin. Ann NY Acad Sci 445:241- 258, 1985 
Bartek J, Taylor-Papadimitriou J, Miller N, Millis R: Patterns of ex- 
VOL. 92, NO. 5 MAY 1989 SEQUENCE AND FUNCTION OF KERATIN 19 715 
pression of keratin 19 as detected with monoclonal antibodies in 
human breast tissues and tumors. Int J Cancer 36:299- 306, 1985 
9. Moll R, Levy R, Czernobilsky B, Hohlweg-Mejert P, Dallenbach- 
Hellweg G, Franke WW: Cytokeratins of normal epithelia and 
some neoplasms of the female genital tract. Lab Invest 49:599-610, 
1983 
10. van Muijen GNP, Warnaar SO, Ponec M: Differentiation-related 
changes of cytokeratin expression in cultured keratinocytes and in 
fetal, newborn and adult epidermis. Exper Cell Res 171:334-345, 
1987 
1 I. Nagle RB, Moll R, Weidauer H, Nemetscheck H, Franke WW: Dif- 
ferent patterns of cytokeratin expression in the normal epithelia of 
the upper respiratory tract. Differentiation 30:130- 140, 1985 
12. Bartek J, Bartkova J, Taylor-Papadimitriou J, Reijthar A, Kovarik J, 
Lukas Z, Vojtesek B: Differential expression of keratin 19 in normal 
human epithelial tissues revealed by monospecific monoclonal anti- 
bodies. Histochem J 18:565 - 575, 1986 
13. Bader BL, Magin TM, Hatzfeld M, Franke WW: Amino acid se- 
quence and gene organization of cytokeratin no. 19, an exceptional 
tail-less intermediate filament protein. EMBO J 5:1865- 1875, 
1986 
14. Stasiak PC, Lane EB: Sequence of cDNA coding for human keratin 19. 
Nucl Acids Res 15:10058, 1987 
15. Eckert RL: Sequence of the human 40-kDa keratin reveals an unusual 
structure with very high sequence identity to the corresponding 
bovine keratin. Proc NatI Acad Sci USA 85:1114 - 1118, 1988 
16. MoIl R, Franke WW, VoIc-Platzer B, Krepler R: Different keratin 
polypeptides in epidermis and other epithelia of human skin: a spe- 
cific cytokeratin of molecular weight 46,000 in epithelia of the 
pilosebaceous tract and basal cell epitheliomas. J Cell Biol95:285 - 
295, 1982 
17. Moll R, Moll I, Wiest W: Changes in the pattern of cytokeratin 
polypeptides in epidermis and hair follicles during skin development 
in human fetuses. Differentiation 23:170- 178, 1982 
18. Lane EB: Monoclonal antibodies provide specific intramolecular 
markers for the study of epithelial tonofilament organisation. J Cell 
Biol 92:665-673, 1982 
19. Taylor-Papadimitriou J, Purkis P, Lane EB, McKay IA, Chang SE. 
Effects of SV40 transformation on the cytoskeleton and behavioural 
properties of human keratinocytes. Cell Diff 11:169- 180, 1982 
20. Lane EB, Lane DP: A rapid antibody assay system for screening hybri- 
doma cultures. J Immunol Meth 47:303-307, 1981 
21. Karsten U, Papsdorf G, Roloff G, Stolley P, Abel H, Walther I, Weiss 
H: Monoclonal anticytokeratin antibody from a hybridoma clone 
generated by electrofusion. Eur J Cancer Clin OncoI 21:733-740, 
1985 
22. Gigi-Leitner 0, Geiger B: Antigenic interrelationship between the 
40-kilodalton cytokeratin polypeptide and desmoplakins. Cell 
Motil Cytosk 6:628-639, 1986 
23. Nagle RB, Lucas DO, McDaniel KM, Clark VA, Schmalzel GM: New 
evidence linking mammary and extramammary Paget cells to a 
common cell phenotype. Am J Clin Path 83:431-438,1985 
24. Woodcock-Mitchell J, Eichner R, Nelson WG, Sun T-T: Immunolo- 
cahzation of keratin polypeptides in human epidermis using mono- 
clonal antibodies. J Cell Biol 95:580-588, 1982 
25. Pruss RM, Mirsky R, Raff MC, Thorpe R, Dowding AJ, Anderton 
BH: All classes of intermediate filaments share a common antigenic 
determinant defined bt a monoclonal antibody. Cell 27:419-428, 
1981 
26. O’Farrell PH: High resolution two-dimensional electrophoresis of 
proteins. J Biol Chem 250:4007-4021, 1975 
27. O’Farrell PZ, Goodman HM, O’Farrell PH: High resolution two-di- 
mensional electrophoresis of basic as well as acidic proteins. Cell 
12:1133-1142, 1977 
28. Towbin H, Staehelin T, Gordon J: Electrophoretic transfer ofproteins 
from polyacrylamide gels to nitrocellulose sheets. Proc NatI Acad 
Sci USA 76:4350-4354. 1979 
29. Hancock K, Tsang VCW: India ink staining on nitrocellulose paper. 
Anal Biochem 133:157-162, 1983 
30. Young RA, Davis RW: Efficient isolation of genes by using antibody 
probes. Proc Nat1 Acad Sci USA 80:1194-1198, 1983 
31. Ruther U, Miiller-Hill B: Easy identification of cDNA clones. EMBO 
J 2:1791-1794, 1983 
32. Messing J. Vieira J: The pUC pl asmids, an Ml3 mp7-derived system 
for insertion mutagenesis and sequencing with synthetic universal 
primers. Gene 19:259-268, 1982 
33. Norrander J, Kempe T, Messing J: Construction of improved Ml3 
vectors using ohgonucleotide-directed mutagenesis. Gene 26:101- 
106, 1983 
34. Sanger F, Nicklen S, Co&on AR: DNA sequencing with chain-termi- 
nating inhibitors. Proc Nat1 Acad Sci 75:5463 - 5467, 1977 
35. Staden R: Automation of the computer handling of gel reading data 
produced by the shotgun method of DNA sequencing. Nucl Acids 
Res 10:4731-4751,1982 
36. Garnier J, Osguthorpe DJ. Robson B: Analysis of the accuracy and 
implications of simple methods for predicting the secondary struc- 
ture of globular proteins. J Mol Biol 120:97- 120, 1978 
37. Novotny J, Auffray C: A program for prediction of protein secondary 
structure from nucleotide sequence data: application to histocom- 
patibility antigens. Nucl Acids Res 12:243-255, 1984 
38. Mall R, Moll I, Franke WW: Identification of Merkel cells in human 
skin by specific cytokeratin antibodies: changes of cell density and 
distribution in fetal and adult plantar epidermis. Differentiation 
28:136-154, 1984 
39. Gigi-Leitner 0, Geiger B, Levy R, Czernobilsky B: Cytokeratin ex- 
pression in sqamous metaplasia of the human uterine cervix. Differ- 
entiation 31:191-205, 1986 
40. Morgan PR, Leigh IM, Purkis PE, Gardner ID, van Muijen GNP, Lane 
EB: Site variation in keratin expression in human oral epithelia-an 
immunocytochemical study of individual keratins. Epitheha I:31 - 
43, 1987 
41. Morgan PR, Johnson NW, Leigh IM, Lane EB: Structure of gingival 
epithelium as revealed by monoclonal antibodies to keratins. In: 
Lehner T, Cimasoni G (eds.). Borderland between Caries and Perio- 
dontal disease III. Medicine and Hygiene, Geneva, 1986, pp 46-59 
42. Chaudary MA, MiIIis RR, Lane EB, Miller NA: Paget’s disease of the 
nipple: a ten year review including clinical, pathological and im- 
munohistochemical findings. Breast Cant Res Treatm 8:139- 146, 
1986 
43. Taylor-Papadimitriou J, Lane EB: Keratin expression in the mammary 
gland. In: Neville MC, Daniel CW (eds.). The Mammary Gland. 
Plenum, New York, 1987, pp 181-215 
44. Kozak M: Point mutations define a sequence flanking the AUG initia- 
tor codon that modulates translation by eukaryotic ribosomes. Cell 
44:283-292, 1986 
45. Kozak M: Comparison of initiation of protein synthesis in procaryotes, 
eukaryotes, and organelles. Microbial Rev 47:1-45, 1983 
46. Eckert RL, Green H: Cloning of cDNAs specifying vitamin A-respon- 
sive human keratins. Proc NatI Acad Sci USA 81:4321-4325,1984 
47. Crick, FH: The packing of a-helices: simple coiled-coils. Acta Crystal 
6:687-688 
48. Steinert PM, Parry DAD: Intermediate filaments: conformity and di- 
versity of expression and structure. Ann Rev Cell Biol I:41 -65, 
1985 
49. Yaffe D, Nude1 U, Mater Y, Neuman S: Highly conserved sequences 
in the 3’ untranslated region of mRNAs coding for homologous 
proteins in distantly related species. NucI Acids Res 13:3723 - 3737, 
1985 
50. Steinert PM, Parry DAD, Idler WW, Johnson LD, Steven AC, Roop 
DR: Amino acid sequences of mouse and human epidermal type II 
keratins of Mr 67,000 provide a systematic basis for the structural 
and functional diversity of the end domains of keratin intermediate 
filament subunits. J Biol Chem 260:7142-7149, 1985 
5 1. Khnge EM, Sylvestre YR, Freedberg IM, Blumenberg M: Evolution of 
keratin genes: different protein domains evolve by different path- 
ways. J Mol Evol 24:319-329, 1987 
52. Hanukoglu I, Fuchs E: The cDNA sequence of a human epidermal 
keratin: Divergence of sequence but conservation of structure 
among intermediate filament proteins. Cell 31:243-252, 1982 
53. Steinert PM, Rice RH, Roop DR. Trus BL, Steven AC: Complete 
amino acid sequence of a mouse epidermal keratin subunit and im- 
plications for the structure of intermediate filaments. Nature 
302:794-800, 1983 
54. Miyatani S, Winkles JA, Sargent TD, Dawid IB: Stage-specific kera- 
tins in Xenopus la& embryos and tadpoles: The XK81 gene family. 
J Cell BioI 103:1957-1965, 1986 
716 STASIAK ET AL THE JOURNAL OF INVESTIGATIVE DERMATOLOGY 
55. Glass C, Kim KH, Fuchs E: Sequence and expression ofa human type II 
mesothelial keratin. J Cell Biol 101:2366-2373, 1985 
56. Leube RE, Bosch FX, Roman0 V, Zimbelmann R, Hofler H, Franke 
WW: Cytokeratin expression in simple epithelia III. Detection of 
mRNAs encoding human nos. 8 and 18 in normal and tumour cells 
by hybridization with cDNA sequences in vitro and in situ. Differ- 
entiation 33:69-85, 1986 
57. Magin TM, Jorcano JL, Franke WW: Cytokeratin expression in sim- 
ple epithelia II. cDNA cloning and sequence characteristics of bo- 
vine cytokeratin A (no. 8). Differentiation 30:254-264, 1986 
58. Oshima RG, Milan JL, Cecena G: Comparison of mouse and human 
keratin 18: A component of intermediate filaments expressed prior 
to implantation. Differentiation 33:61-68, 1986 
59. Roman0 V, Hatzfeld M, Magin TM, Zimbelmann R, Franke WW, 
Maier G, Ponting H: Cytokeratin expression in simple epithelia. I. 
Identification of mRNA coding for human cytokeratin no. 18 by a 
cDNA clone. Differentiation 30:244-253, 1986 
60. Singer PA, Trevor K, Oshima RG: Molecular cloning and character- 
ization of the Endo B cytokeratin expressed in preimplantation 
mouse embryos. J Biol Chem 261:538-547, 1986 
6 1. Geisler N, Weber K: Amino acid sequence data on glial fibrillary acidic 
protein (GFA); implications for the subdivision of intermediate hla- 
ments into epithelial and non-epithelial members. EMBO J 
2:2059-2063,1983 
62. Jorcano JL, Rieger M, Franz JK, Schiller DL, Moll R, Franke WW: 
Identification of two types of keratin polypeptides within the acidic 
cytokeratin subfamily I. J Mol Biol 179:257-281, 1984 
63. Knapp B, Rentrop M, Schweizer J, Winter H: Three cDNA sequences 
of mouse type I keratins. Cellular localization of the mRNAs in 
normal and hyperproliferative tissues. J Biol Chem 262:938-945, 
1987 
64. Knapp B, Rentrop M, Schweizer J Winter H: cDNA sequences and in 
situ localization of the mRNAs. Nucl Acids Res 14:751-763,1986 
65. Leube RE, Bader BL, Bosch FX, Zimbelmann R, Achtstatter T, Franke 
WW: Molecular characterization and expression of the stratifica- 
tion-related cytokeratins 4 and 15. J Cell Bio1 106:1249-1261, 
1988 
66. Rosenberg M, RayChaudury A, Snows TB, LeBeau M, Fuchs E: A 
group of type I keratin genes on human chromosome 17: Character- 
ization and expression. Mol Cell Biol 8:722-736, 1988 
67. Darmon MY, S&mat A, Darmon MC, Vasseur M: Sequence of a cDNA 
encoding human keratin No. 10 selected according to structural 
homologies of keratins and their tissue-specific expression. Mol Bio1 
Rep 12:277 - 283, 1987 
68. Rieger M, Jorcano JL, Franke WW: Complete sequence of a bovine 
type I cytokeratin gene: conserved and variable positions in genes of 
polypeptides of the same cytokeratin subfamily. EMBO J 4:2261- 
2267,1985 
69. Winkles JA, Sargent TD, Parry DAD, Jonas E, Dawid IB: Develop- 
mentally regulated cytokeratin gene in Xenopus La&. Mol Cell 
Bio1 5:2575-2581, 1985 
70. Hoffman W, Franz JK: Amino acid sequence of the carboxy-terminal 
part of an acidic type I cytokeratin of molecular weight 51000 from 
Xenopus Lawis epidermis as predicted from the cDNA sequence. 
EMBO J 6:1301- 1306, 1984 
71. Dowling LM, Crewther WG, Inglis AS: The primary structure of 
component 8c-1, a subunit protein of intermediate filaments in wool 
keratin. Relationships with proteins from other intermediate fila- 
ments. Biochem J 236:695-703, 1986 
72. Kaufmann E, Weber K, Geisler N: Intermediate filament forming 
ability of desmin derivatives lacking either the amino-terminal 67 or 
the carboxy-terminal 27 residues. J Mol Biol 185:733-742, 1985 
73. Geisler N, Fischer S, Vandekerckhove J, Plessmann U, Weber K: 
Hybrid character of a large neurofilament protein (NF-M): interme- 
diate filament type sequence followed by a long and acidic carboxy- 
terminal extension. EMBO J 3:2701-2706, 1984 
74. Roberts GP, Brunt J: Biosynthesis of a glycosylated keratin by human 
keratinocytes. Biochem Biophys Acta 883:413-419, 1986 
75. Vidrich A, Gilmartin M, Ryan K, Freedberg IM: Localization of phos- 
phate and glycosamine on keratins of ME180 cells (abstr). J Invest 
Dermatol 82:403, 1984 
76. Dale BA, Holbrook KA, Kimball JR, Hoff M, Sun T-T: Expression of 
epidermal keratins and filaggrin during human fetal skin develop- 
ment. J Cell Bio1 101:1257- 1269, 1985 
77. Al-Barwari SE, Potten CS: Regeneration and dose-response character- 
istics of irradiated mouse dorsal epidermal cells. Int J Radiat Biol 
30:201-216, 1976 
78. Winter GD: Epidermal regeneration studied in the domestic pig. In: 
Maibach HI, Rovee DT (eds.). Epidermal Wound Healing. Year 
Book Medical Publishers, Chicago, 1972, pp 71- 112 
79. Hunter JAA, Mcittie E, Comaish JS: Light and electron microscopic 
studies of physical injury to the skin I: Suction. Br J Dermatol 
90:481-490, 1974 
80. Schermer A, Galvin S, Sun T-T: Differentiation-related expression of 
a major 64K cornea1 keratin in vivo and in culture suggests limbal 
location of cornea1 epithelial stem cells. J Cell Bio1 103:49-62, 
1986 
81. Roop DR, Huitfeldt H, Kilkenny A, Yuspa SH: Regulated expression 
of differentiation-associated keratins in cultured epidermal cells de- 
tected by monospecific antibodies to unique peptihes of mouse epi- 
dermal keratins. Differentiation 35:143- 150, 1987 
